Related Experiment Video
Updated: Jun 26, 2026

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion
Published on: July 7, 2023
Clinicopathology of stromal invasion in lung adenocarcinoma
Atsushi Fujita1, Yoichi Kameda, Tomoyuki Goya
1Department of Pathology, Kanagawa Cancer Center, Tokyo, Japan. IZS02635@nifty.com
Abstract:
In the World Health Organization classification, lung adenocarcinoma with mixed subtypes is defined as invasive carcinoma with evidence of vascular, pleural, or stromal invasion. The histological criteria for stromal invasion, however, are not clearly established. A total of 157 peripheral pure bronchioloalveolar carcinoma (BAC) or lung adenocarcinoma with mixed BAC and others were reviewed. All cases had been resected between 1986 and 2000 and measured < or =30 mm in maximum dimension. Destruction of alveolar framework (DAF) was defined as distortion or discontinuity of the alveolar framework by tumor growth. The extra-alveolar area involvement (EAAI) was defined as tumor growth outside the alveolar framework, which includes the following areas: bronchial wall, perivascular connective tissue and/or the vascular wall, interlobular septum and the visceral pleura. Survival of patients with adenocarcinoma without DAF (n = 41) was 100%. Even when adenocarcinoma involved DAF and lacked EAAI (n = 21), survival was 100%. The 5 year survival rate of groups with two invasion signs (n = 34) was 90.1%, and that of groups with three to five invasion signs (n = 61) was 66.7%. Tumor growth outside the alveolar framework is the hallmark of stromal invasion.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia
The Tumor Microenvironment
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
